The Biomerica COVID-19 IgG/IgM Rapid Test is a qualitative rapid immunoassay for the detection of IgG and IgM antibodies to SARS-CoV-2 in whole blood, serum or plasma specimens. The specimen reacts with SARS-CoV-2 coupled gold conjugate and then reacts with anti-human IgM and/or antihuman IgG in the test line region if the specimen contains antibodies directed to SARS-CoV-2.
has commenced shipping initial samples of its COVID-19 IgG/IgM Rapid Test (a finger prick blood test with results in 10 minutes, that can be performed by trained professionals anywhere, e.g. airports, schools, work, pharmacies and doctors’ offices) to countries outside the United States. Evaluation test kits have been requested by Ministries of Health in multiple countries through the Company’s distribution partners who are working with their government agencies to assess the tests and forecast demand.